B.
Pérez Valderrama
Publicacións nas que colabora con B. Pérez Valderrama (1)
2017
-
Weekly cabazitaxel plus prednisone is effective and less toxic for ‘unfit’ metastatic castration-resistant prostate cancer: Phase II Spanish Oncology Genitourinary Group (SOGUG) trial
European Journal of Cancer, Vol. 87, pp. 30-37